Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
3692 Hansoh Pharmaceutical Group	HK$17.38	-1.5%	33.1%	HK$103.5b	HK$19.45	PE29.2x	E8.6%	1.6%
1093 CSPC Pharmaceutical Group	HK$6.60	-4.3%	-6.8%	HK$79.0b	HK$9.58	PE12x	E4.5%	4.2%
1801 Innovent Biologics	HK$37.40	7.3%	11.3%	HK$61.9b	HK$55.16	PS9.1x	E50.8%	n/a
1177 Sino Biopharmaceutical	HK$2.75	1.1%	-25.9%	HK$50.4b	HK$4.58	PE25.4x	E14.3%	1.8%
2269 WuXi Biologics (Cayman)	HK$11.68	6.4%	-69.9%	HK$49.4b	HK$26.44	PE13.3x	E13.9%	n/a
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$179.20	3.4%	n/a	HK$38.4b	HK$199.22	PS24.1x	E30.8%	n/a
3320 China Resources Pharmaceutical Group	HK$5.85	1.9%	-13.8%	HK$36.8b	HK$7.38	PE8.9x	E7.0%	2.8%
9926 Akeso	HK$38.10	-1.6%	8.5%	HK$35.3b	HK$59.05	PE15.1x	E10.2%	n/a
1877 Shanghai Junshi Biosciences	HK$11.78	-3.3%	-50.6%	HK$26.7b	HK$23.10	PS6.6x	E26.2%	n/a
9995 RemeGen	HK$26.15	1.2%	-26.3%	HK$23.5b	HK$39.98	PS10.5x	E54.9%	n/a
570 China Traditional Chinese Medicine Holdings	HK$4.25	-0.9%	12.1%	HK$21.5b	HK$4.93	PE15.5x	E10.5%	0%
2268 WuXi XDC Cayman	HK$16.84	11.2%	n/a	HK$20.0b	HK$31.12	PE66.1x	E44.6%	n/a
1548 Genscript Biotech	HK$9.08	-3.4%	-52.0%	HK$19.3b	HK$25.03	PS2.9x	E97.9%	0%
2228 QuantumPharm	HK$5.28	n/a	n/a	HK$18.0b	n/a	PS95.8x	n/a	n/a
867 China Medical System Holdings	HK$7.04	-0.3%	-45.5%	HK$17.2b	HK$10.90	PE6.6x	E6.8%	6.0%
512 Grand Pharmaceutical Group	HK$4.86	0.8%	9.2%	HK$16.7b	n/a	PE9.1x	E13.9%	5.3%
3933 United Laboratories International Holdings	HK$8.58	0%	14.2%	HK$15.8b	HK$12.28	PE5.4x	E1.7%	6.5%
6826 Shanghai Haohai Biological Technology	HK$31.50	5.4%	36.7%	HK$15.4b	HK$35.72	PE12.2x	E18.2%	2.4%
2096 Simcere Pharmaceutical Group	HK$5.78	-1.9%	-20.5%	HK$15.1b	HK$8.59	PE19.1x	E23.7%	3.0%
1530 3SBio	HK$6.20	-0.3%	-15.5%	HK$14.7b	HK$7.45	PE8.8x	E12.7%	4.0%
2005 SSY Group	HK$4.75	1.9%	-7.4%	HK$14.0b	HK$6.23	PE10.7x	E15.0%	3.6%
6600 SciClone Pharmaceuticals (Holdings)	HK$18.60	0.2%	69.4%	HK$11.3b	HK$17.86	PE9.4x	E4.7%	0%
2186 Luye Pharma Group	HK$2.85	1.4%	-26.9%	HK$10.7b	HK$3.05	PE18.7x	E26.8%	0%
2696 Shanghai Henlius Biotech	HK$18.84	0%	59.1%	HK$10.2b	HK$18.03	PE17.4x	E15.8%	n/a